Locations

Showing 1137 Locations
Sort by:
  • Berkeley, California, USA

    Sage Integrative Health • Alexander Shulgin Research Institute • Berkeley Center for the Science of Psychedelics (BCSP)

    Operations Manager • Psychiatry position • Development Director

  • Berlin, Germany

    ATAI Life Sciences • Introspect • Psychedelic Society Berlin • PsychonautWiki • Viridia Life Science • Charite University, Berlin, Germany • MIND Foundation • Empath Bio • OVID Health Systems • German Federal Ministry of Education and Research

    ATAI Life Sciences AG • Masawa Management • Berggruen Holdings

    Florian Brand • Simon Seibold • Joshua Haynes

    Internship - Business Operations • Business Operations & Strategy Manager (m/w/d) • Business Operations Intern • Business Associate • Working Student - Business Operations • Head of Investment (m/w/d) • Business Operations & Strategy Manager (m/w/d) • VP Human Resources/People • VP of Investment

    Ketamine-Induced Brain Changes and Their Modulation by Lamotrigine • Once-Nightly Sodium Oxybate for Treatment of Excessive Daytime Sleepiness and Cataplexy in Narcolepsy • A Safety and Efficacy Study of Xyrem® (Sodium Oxybate) to Treat Fibromyalgia. • Observational Study to Evaluate Risks of Side Effects, Drug Abuse and Dependence in Patients Who Received Xyrem ® on Prescription

  • Berlin, New Jersey, USA

    A Study to Assess the Electrophysiology, Safety, Tolerability, and Pharmacokinetics of SAGE-718 Using a Ketamine Challenge in Healthy Subjects • A Study to Assess Electrophysiology, Safety, Tolerability, and Pharmacokinetics of Multiple Doses of SAGE-718 Using Ketamine Challenge in Healthy Subjects • A Study to Assess the Electrophysiology, Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Response Using Magnetic Resonance Imaging of SAGE-718 Using a Ketamine Challenge in Healthy Subjects • Proof of Concept Study Evaluating the Efficacy and Safety of MIJ821 in Patients With Treatment-resistant Depression • A Safety and Efficacy Study of Xyrem® (Sodium Oxybate) to Treat Fibromyalgia.

  • Bern, Switzerland

    Psychedelic Society Switzerland • Schweizerischer Nationalfonds • University of Bern

    Observational Study to Evaluate Risks of Side Effects, Drug Abuse and Dependence in Patients Who Received Xyrem ® on Prescription

  • Besançon, Bourgogne-Franche-Comté, France

    The Effect of Minocycline on Relapse After Successful Intravenous Ketamine/Minocycline-induced Symptoms Response in Subjects With Depression

  • Bethesda, Maryland, USA

    National Institute on Drug Abuse (NIDA) • National Institute of Neurological Disorders and Stroke (NINDS) • National Institutes of Health Clinical Center (CC) • National Institute on Minority Health and Health Disparities (NIMHD) • National Institutes of Health (NIH) • National Institute of Mental Health (NIMH) • National Cancer Institute (NCI) • National Institute of General Medical Sciences (NIGMS) • National Institute of Nursing Research (NINR) • Mid-Atlantic Epilepsy and Sleep Center, LLC • National Center for Research Resources (NCRR) • National Institute on Deafness and Other Communication Disorders (NIDCD) • National Institute on Aging (NIA) • Walter Reed National Military Medical Center

    Evaluating Ketamine and Psychological Sequelae • Retrospective Evaluation of Ketamine Effectiveness for the Treatment of Acute Battlefield Related Pain • A Proof-of-Concept Trial on the Effect of Ketamine on Fatigue • Neuropharmacologic Imaging and Biomarker Assessments of Response to Acute and Repeated-Dosed Ketamine Infusions in Major Depressive Disorder • Mechanism of Action Underlying Ketamine s Antidepressant Effects: The AMPA Throughput Theory in Patients With Treatment-Resistant Major Depression • Effect of Ketamine on Fatigue Following Cancer Therapy • Levetiracetam, Lacosamide and Ketamine as Adjunctive Treatment of Refractory Status Epilepticus • Rapid Antidepressant Effects of Ketamine in Major Depression • Neurobiology of Suicide

  • Bettendorf, Iowa, USA

    Baclofen-Amitriptyline Hydrochloride-Ketamine Gel in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer

  • Beverly Hills, California, USA

    Trial Comparing the Effects of Xyrem (Sodium Oxybate) With Placebo for the Treatment of Fibromyalgia

  • Biberist, Solothurn, Switzerland

    Study of 3,4-Methylenedioxymethamphetamine-assisted Psychotherapy in People With Posttraumatic Stress Disorder

  • Billings, Montana, USA

    Baclofen-Amitriptyline Hydrochloride-Ketamine Gel in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer

  • Bingham Farms, Michigan, USA

    Multiple-dose,Double-blind,Placebo-controlled Study of Sodium Oxybate in Patients With Essential Tremor • A Safety and Efficacy Study of Xyrem® (Sodium Oxybate) to Treat Fibromyalgia.

  • Birmingham, Alabama, USA

    University of Alabama at Birmingham

    Psilocybin-facilitated Treatment for Cocaine Use • Intranasal Versus Intravenous Ketamine for Procedural Sedation in Children With Non-operative Fractures • A Study to Evaluate Ketamine for the Treatment of Rett Syndrome • Intraoperative Low-dose Ketamine Infusion for Patients With Obstructive Sleep Apnea • Efficacy of Ketamine Infusion Compared With Traditional Anti-epileptic Agents in Refractory Status Epilepticus • A Study of Ketamine in Patients With Treatment-resistant Depression • miRNAs, Suicide, and Ketamine - Plasma Exosomal microRNAs as Novel Biomarkers for Suicidality and Treatment Outcome • Treatment of Suicidal Ideation With Intravenous Ketamine Infusion • Safety and Efficacy of Repeated Doses of PMI-150 (Intranasal Ketamine) in Acute Post-operative Pain Following Orthopedic Surgery • Proof of Concept Study Evaluating the Efficacy and Safety of MIJ821 in Patients With Treatment-resistant Depression • Sequential Therapy for the Treatment of Severe Bipolar Depression. • Once-Nightly Sodium Oxybate for Treatment of Excessive Daytime Sleepiness and Cataplexy in Narcolepsy • Safety and Efficacy of Xyrem Oral Solution (Sodium Oxybate) Compared With Placebo in Narcoleptic Patients • A Safety and Efficacy Study of Xyrem® (Sodium Oxybate) to Treat Fibromyalgia.

  • Birmingham, England, United Kingdom

    Psychedelic Society of Birmingham

  • Bismarck, North Dakota, USA

    Baclofen-Amitriptyline Hydrochloride-Ketamine Gel in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer

  • Bixby, Oklahoma, USA

    Neuma Coaching

  • Blacksburg, Virginia, USA

    Virginia Polytechnic Institute and State University

  • Bloomington, Illinois, USA

    Indiana University

    Baclofen-Amitriptyline Hydrochloride-Ketamine Gel in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer

  • Bloomington, Minnesota, USA

    HealthPartners Institute

  • Blumenau, Santa Catarina, Brazil

    Intramuscular Ketamine Versus Aripiprazole and Escitalopram in the Treatment of Resistant Depression

  • Boardman, Ohio, USA

    Sub-Dissociative Ketamine and Fentanyl to Treat Moderate to Severe Pain

  • Bobigny, Île-de-France, France

    Ketamine Versus Etomidate During Rapid Sequence Intubation: Consequences on Hospital Morbidity

  • Böblingen, Baden-Württemberg, Germany

    Safety and Efficacy Study of Xyrem® (Sodium Oxybate) in Subjects With Fibromyalgia. • A Safety and Efficacy Study of Xyrem® (Sodium Oxybate) to Treat Fibromyalgia.

  • Boca Raton, Florida, USA

    Psybio Therapeutics • Florida Atlantic University

    Robert Streisfeld • Scott Fisher

  • Bologna, Emilia-Romagna, Italy

    Azienda Ospedaliera Universitaria di Bologna Policlinico S. Orsola Malpighi • University of Bologna

    Comparative Study of Gamma-hydroxy Butyrate Versus Oxazepam in the Treatment of Alcohol Withdrawal Syndrome • Observational Study to Evaluate Risks of Side Effects, Drug Abuse and Dependence in Patients Who Received Xyrem ® on Prescription

  • Bolton, England, United Kingdom

    Safety and Efficacy Study of Xyrem® (Sodium Oxybate) in Subjects With Fibromyalgia. • A Safety and Efficacy Study of Xyrem® (Sodium Oxybate) to Treat Fibromyalgia.

  • Bonn, North Rhine-Westphalia, Germany

    University of Bonn

    Effects of Ketamine on Eye Movements, Perception and Brain Function

  • Boone, North Carolina, USA

    Safety and Efficacy Study of Xyrem® (Sodium Oxybate) in Subjects With Fibromyalgia. • A Safety and Efficacy Study of Xyrem® (Sodium Oxybate) to Treat Fibromyalgia.

  • Bordeaux, Nouvelle-Aquitaine, France

    University Hospital, Bordeaux • Institut Bergonié

    Intravenous Subdissociative-dose Ketamine Versus Morphine for Prehospital Analgesia • Administration of Ketamine to Prevent the Post-operative Pain • Polyamine-free Diet to Prevent Post Surgery Hyperalgesia

  • Boston, Massachusetts, USA

    Eleos • Center for the Neuroscience of Psychedelics • Adelia Therapeutics • Vicente Sederberg • Brigham and Women's Hospital • Boston University • Harvard Medical School • Boston Children's Hospital • Invicro • Massachusetts General Hospital • Beth Israel Deaconess Medical Center • Beth Israel Medical Center • Massachusetts Eye and Ear Infirmary • Tufts Medical Center • Concert Pharmaceuticals • Psy Therapeutics • Hyka Therapeutics

    MAZAKALI • Psilos Group

    Bob Peatman • Stephen Krupa • Joseph Tucker • Doug Drysdale • Adam Von Reyn

    Program Manager - Center for Neuroscience of Psychedelics • Director Quality Assurance Regulatory Affairs • Director Clinical Operations • Director, Clinical Operations • Formulation/Analytical Chemist • Director, Quality Assurance

    A Multi-Site Phase 3 Study of MDMA-Assisted Psychotherapy for PTSD (MAPP1) • A Multi-Site Phase 3 Study of MDMA-Assisted Psychotherapy for PTSD • EEG Studies of Ketamine General Anesthesia • Ketamine for Depression: An MRI Study • Physiological and Cognitive Biomarkers for Ketamine's Antidepressant Effects • A Study to Evaluate Ketamine for the Treatment of Rett Syndrome • Ketamine Infusion for Treatment-resistant Major Depressive Disorder • Immunomodulatory Properties of Ketamine in Sepsis • A Study of Brexpiprazole Plus Ketamine in Treatment-Resistant Depression (TRD) • Prevention of Post Mastectomy With Intraoperative Ketamine • The Effects of Ketamine on Respiratory Stimulation and Transpulmonary Pressures • Ketamine Versus Placebo for Treatment Resistant Major Depressive Disorder • Effect of Ketamine on Opioid-Induced Hyperalgesia • Efficacy Study of Ketamine for Postoperative Pain in Opioid Dependent Patients • Ketamine for Major Depressive Disorder • The Impact of Ketamine on the Reward Circuitry of Suicidal Patients • Double-Blind, Placebo-Controlled Trial of Ketamine Therapy in Treatment-Resistant Depression (TRD) • Remifentanil Plus Ketamine for Dynamic Flexible Bronchoscopy • Ketamine and Scopolamine Infusions for Treatment-resistant Major Depressive Disorder • Safety and Efficacy of PMI-150 (Intranasal Ketamine) for the Treatment of Breakthrough Pain in Cancer Patients • N-methyl-D-aspartate Antagonist (Ketamine) Augmentation of Electroconvulsive Treatment for Severe Major Depression • EEG Studies of Sevoflurane-Induced General Anesthesia • Avoiding Neuromuscular Blockers to Reduce Complications • Prevention of Phantom Limb Pain After Transtibial Amputation • The PATHFINDER Study: A Feasibility Trial • EEG Monitoring in the Emergency Department • Sodium Oxybate in Spasmodic Dysphonia and Voice Tremor • The Effect of Sodium Oxybate on Sleep Architecture • Evaluation of the Efficacy of Sodium Oxybate (Xyrem®) in Treatment of Post-traumatic Narcolepsy and Post-traumatic Hypersomnia

  • Bothell, Washington, USA

    Alder Biopharmaceuticals, Inc.

  • Boulder, Colorado, USA

    Naropa University • Medicinal Mindfulness • The Awake Network • Magic Agency • Gaia • Psychedelic Club • Integrative Psychiatry Institute

    Larry Norder

    Study Coordinator

    Open Label Multi-Site Study of Safety and Effects of MDMA-assisted Psychotherapy for Treatment of PTSD • A Multi-Site Phase 3 Study of MDMA-Assisted Psychotherapy for PTSD (MAPP1) • A Multi-Site Phase 3 Study of MDMA-Assisted Psychotherapy for PTSD • Psychological Effects of Methylenedioxymethamphetamine (MDMA) When Administered to Healthy Volunteers • Dose-Response Study of MDMA-assisted Psychotherapy in People With PTSD • Once-Nightly Sodium Oxybate for Treatment of Excessive Daytime Sleepiness and Cataplexy in Narcolepsy • An Open Label Study of FT218 in Subjects With Narcolepsy • A Study of the Efficacy and Safety of JZP-258 in Subjects With Narcolepsy With Cataplexy

  • Boulogne-Billancourt, Île-de-France, France

    Hospital Ambroise Paré Paris

  • Bourgogne-Franche-Comté, France

    Centre Hospitalier Universitaire de Besancon

  • Bowling Green, Kentucky, USA

    Trial Comparing Effects of Xyrem Taken Orally and Modafinil With Placebo in Treating Daytime Sleepiness in Narcolepsy • Safety and Tolerability Study Comparing Sodium Oxybate Given as an Oral Solution to a Single-blinded Combination of Oral Tablets Plus Oral Solution in Subjects With Fibromyalgia • Safety and Efficacy Study of Xyrem® (Sodium Oxybate) in Subjects With Fibromyalgia.

  • Bowling Green, Ohio, USA

    Baclofen-Amitriptyline Hydrochloride-Ketamine Gel in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer

  • Bradenton, Florida, USA

    Proof of Concept Study Evaluating the Efficacy and Safety of MIJ821 in Patients With Treatment-resistant Depression

  • Brasilia, Brazil

    Conselho Nacional de Desenvolvimento Científico e Tecnológico

  • Bratislava, Slovakia

    Slovak psychedelic society - SAPAS

  • Brazil

    Centro Medico Campinas • Coordenação de Aperfeiçoamento de Pessoal de Nível Superior.

  • Breda, North Brabant, Netherlands

    Safety and Efficacy Study of Xyrem® (Sodium Oxybate) in Subjects With Fibromyalgia. • A Safety and Efficacy Study of Xyrem® (Sodium Oxybate) to Treat Fibromyalgia.

  • Bremen, Germany

    Observational Study to Evaluate Risks of Side Effects, Drug Abuse and Dependence in Patients Who Received Xyrem ® on Prescription

  • Brentwood, Tennessee , USA

    Foundations Recovery Network • American College of Neuropsychopharmacology

  • Breslau, Ontario, Canada

    KWCG Psychedelic Society

  • Brisbane, Queensland, Australia

    Once-Nightly Sodium Oxybate for Treatment of Excessive Daytime Sleepiness and Cataplexy in Narcolepsy

  • Bristol, England, United Kingdom

    The Safety and Efficacy of Psilocybin in Participants With Treatment Resistant Depression • Bristol Imperial MDMA in Alcoholism Study

  • British Columbia, Canada

    Medcan Biotechnologies • Optimi Health • HealthTech Connex • Albert Labs

  • Brno, Czechia

    Brno University Hospital

  • Bronx, New York, USA

    Intranasal Ketamine for Suicidal Ideation in Veterans • Intranasal Ketamine For Pain Control In Patients With Sickle Cell Disease And Vaso-occlusive Episode (VOE) In The PED • A Study of Brexpiprazole Plus Ketamine in Treatment-Resistant Depression (TRD) • Once-Nightly Sodium Oxybate for Treatment of Excessive Daytime Sleepiness and Cataplexy in Narcolepsy • An Open Label Study of FT218 in Subjects With Narcolepsy • A Study of the Efficacy and Safety of JZP-258 in Subjects With Narcolepsy With Cataplexy